We have over 20 years of experience investing in biotechnology startups, dating back to our former entity NIF Ventures.

As a sector-focused venture capital firm, we manage the largest size of life science funds in Japan, playing a crucial role in providing risk capital to promising startups.

Our primary goal is to enhance the value of our portfolio companies by providing hands-on support in various ways. This includes leveraging our expertise in clinical development, intellectual property and business development, while utilizing our extensive network with academics, biotechs and pharmas centered on Japan and Taiwan.

Beyond classical venture capital firms, we also aim to act as a platform to incubate seeds that have great potential through a creation of new startups.